Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

Original statement

تكميم اه قاتل قاتل قاتل قاتل قاتل

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

Origin

Source status

Video transcript (own words)

Attribution

Elawady (machine transcript)

Video

Dr Diaa Al Awady د ضياء العوضي is live!لايف مش مهم خالص (Open source)

Published

11 February 2026

Timestamp

0:58:06 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)

Attribution uncertainty

Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.

Claimed mechanism

Removing most of the stomach destroys its function and leads to disease and death.

Claimed health effect

Death; shortened life.

Population concerned

People with obesity considering surgery

Geographic restriction by Elawady

none found

Diverging source versions

Scientific assessment

Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

That sleeve/bariatric surgery is 'lethal' and kills patients.

2. What is demonstrably correct?

Deaths after bariatric surgery do occur: early postoperative mortality is about 0.04-0.3% in large registries/cohorts, and long-term deaths from accidents, suicide and alcohol are more frequent than in non-operated people with obesity (Adams 2007: 11.1 vs 6.4 per 10,000 person-years; SOS 2020: HR 1.85).

3. What is wrong or exaggerated?

As a general statement it is contradicted: overall mortality is lower after surgery (SOS HR 0.77 over 24 years; Adams 40% lower; meta-analysis about 49% lower hazard and +6.1 years median life expectancy, with no difference between sleeve, bypass and banding).

4. What remains unclear?

No randomized trial of survival exists; residual confounding could inflate the benefit. Sleeve-specific very-long-term (>20 years) survival data are limited.

5. Which studies support it?

A-BAR-03 (excess non-disease deaths). A-BAR-16 documents a specific rare harm (increased suicide and self-harm; 42 suicides over about 117,000 post-surgery person-years), but its authors state the findings should not discourage surgery from a survival perspective; it does not show overall life-shortening.

6. Which studies contradict it?

A-BAR-01, A-BAR-02, A-BAR-05, A-BAR-12, I-BAR-01.

7. What applies to Germany and Europe?

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

8. What is known about Egypt?

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

9. What practical conclusion is appropriate?

Bariatric surgery carries real risks, including rare early deaths and an increased risk of suicide, accidents and alcohol problems, but on average it is associated with longer survival in severe obesity.

Assessment details

Rationale for certainty of evidence

Survival data are observational (no randomized survival trials), but large, consistent and long-term (SOS 24 years; meta-analysis of 174,772 people including sleeve). Perioperative mortality is directly measured and low.

Source quality

Elawady's statement is a verbal assertion without cited data. Counter-evidence comes from prospective cohorts, registries and a meta-analysis.

Regional transferability

European data (Sweden) are direct.

Individual exceptions

Individual deaths from complications do occur; risk is higher with complications, poor follow-up, alcohol misuse, or severe comorbidity.

Regional scope of the claim

general (biological/medical)

Last reviewed

25 October 2026 provisional

In plain language

Elawady called sleeve gastrectomy 'lethal'. Large studies do not support this as a general statement. People who had weight-loss surgery lived longer on average than similar people who did not: in Sweden about 3 years longer, in a large meta-analysis about 6 years longer. Deaths within the first weeks after surgery are rare (well below 1%). However, there is a real increase in deaths from suicide, accidents and alcohol after surgery, so mental-health follow-up is important.

Studies on this claim

Regional context

Germany / EU

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

Egypt

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

What applies in my country?

General scientific assessment

Mostly false Bariatric surgery is not lethal on average; it is associated with longer life, but it has specific, rare fatal risks.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

1. Long-term mortality after gastric bypass surgery.. Adams TD et al.. N Engl J Med 2007 · PMID 17715409 · DOI 10.1056/NEJMoa066603
2. Perioperative safety in the longitudinal assessment of bariatric surgery.. Flum DR et al.. N Engl J Med 2009 · PMID 19641201 · DOI 10.1056/NEJMoa0901836
3. Effects of bariatric surgery on mortality in Swedish obese subjects.. Sjöström L et al.. N Engl J Med 2007 · PMID 17715408 · DOI 10.1056/NEJMoa066254
4. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.. Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
5. Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry.. Stenberg E et al.. Ann Surg 2014 · PMID 24374541 · DOI 10.1097/SLA.0000000000000431
6. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.. Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
7. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.. Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1
8. Outcomes of pregnancy after bariatric surgery.. Johansson K et al.. N Engl J Med 2015 · PMID 25714159 · DOI 10.1056/NEJMoa1405789
9. Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies.. Neovius M et al.. Lancet Diabetes Endocrinol 2018 · PMID 29329975 · DOI 10.1016/S2213-8587(17)30437-0